UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 9
September-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2109217


Registration ID:
314950

Page Number

c135-c154

Share This Article


Jetir RMS

Title

IN-SILICO DESIGN AND DOCKING STUDIES OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES OF 2-(1H-BENZOTRIAZOL-1- YL)ACETOHYDRAZIDE

Abstract

Cancer is the second most common cause of death. Despite prominent progress in the field of anticancer agents, many patients suffer from resistance to currently available anticancer drugs and associated adverse effects. In the present work, different novel 1,3,4-Oxadiazole derivatives of 2-(1H-benzotriazol-1-yl) acetohydrazide were designed using ACD Lab Chemsketch12.0 and their properties were predicted using the molinspiration software. The designed leads having required physicochemical properties, drug – likeness and obeying the Lipinski Rule of Five were selected for docking studies via Biovia Discovery Studio. Compounds 3f, 3j and 3g showed excellent activities on Focal adhesion kinase, compounds 3g, 3h and 3f showed good activities on Enoyl-acyl carrier protein reductase and compounds 3f, 3g and 3j showed good activities on 14 α -Demethylase enzyme. Molecular docking studies were done to assess the binding mode and interactions of designed leads to hits at the binding site of the receptors. Results of in-silico studies showed that most of the compound have excellent drug likeness properties and pharmacokinetic profile. Here in we concluded that 1,3,4-Oxadiazole derivatives of 2-(1H-benzotriazol-1-yl) acetohydrazide could be considered as promising scaffolds towards the development of novel anticancer, antibacterial and antifungal agents.

Key Words

Benzotriazole, Oxadiazoles, Anticancer activity, Antibacterial activity, Antifungal activity, In- silico studies, Biovia Discovery Studio

Cite This Article

"IN-SILICO DESIGN AND DOCKING STUDIES OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES OF 2-(1H-BENZOTRIAZOL-1- YL)ACETOHYDRAZIDE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 9, page no.c135-c154, September-2021, Available :http://www.jetir.org/papers/JETIR2109217.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"IN-SILICO DESIGN AND DOCKING STUDIES OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES OF 2-(1H-BENZOTRIAZOL-1- YL)ACETOHYDRAZIDE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 9, page no. ppc135-c154, September-2021, Available at : http://www.jetir.org/papers/JETIR2109217.pdf

Publication Details

Published Paper ID: JETIR2109217
Registration ID: 314950
Published In: Volume 8 | Issue 9 | Year September-2021
DOI (Digital Object Identifier):
Page No: c135-c154
Country: THIRUVANANTHAPURAM, KERALA, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000460

Print This Page

Current Call For Paper

Jetir RMS